AEMD
Aethlon Medical, Inc. [AEMD] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AEMD Stock Summary
Top AEMD Correlated Resources
AEMD
Top 10 Correlated ETFs
AEMD
Top 10 Correlated Stocks
AEMD
In the News
AEMD Financial details
Company Rating
-
Market Cap
3.96M
Income
-12.24M
Revenue
574.25K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
26 Jun 2024
P/E
-0.43
Forward P/E
-
PEG
0.15
P/S
8.73
P/B
0.48
P/C
-
P/FCF
-0.48
Quick Ratio
5.95
Current Ratio
6.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-5.02
EPS next Y
-
EPS next Q
-
EPS this Y
887.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.34%
Revenue last 5Y
20.12%
Revenue Q/Q
-
EPS Q/Q
13.11%
-
-
-
-
SMA20
-29.58%
SMA50
11.11%
SMA100
19.05%
Inst Own
-
Inst Trans
-
ROA
-90%
ROE
-83%
ROC
-1.07%
Gross Margin
-803664%
Oper. Margin
-2074%
Profit Margin
-2010%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.4-7.2
52W High
-93.76%
52W Low
-56.34%
RSI
31.75
Rel Volume
11.53
Avg Volume
7.94K
Volume
91.55K
Perf Week
-24.83%
Perf Month
-34.35%
Perf Quarter
10.81%
Perf Half Y
25.57%
-
-
-
-
Beta
1.936
-
-
Volatility
0.04%, 0.09%
Prev Close
-5.13%
Price
0.4366
Change
-7.77%
Company Profile
- Volume Average 7.94K
- Market Capitalization 3.96M
- Employee 15
- CEO Mr. James B. Frakes M.B.A.
- Headquarters San Diego,CA,US
- IPO Date 1999-03-04
-
Website
https://www.aethlonmedical.com 
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
